{
    "clinical_study": {
        "@rank": "146409", 
        "arm_group": {
            "arm_group_label": "Assessment of Oral HPV Infection", 
            "arm_group_type": "Other", 
            "description": "Oral HPV infection will be assessed 14 times, once prior to starting CRT, weekly during CRT, and then serially post-treatment: 4-8 weeks, 3 months, 6 months, 12 months, 18 months, 24 months.  Patients will provide samples of their saliva and exfoliated epithelial cells at these timepoints.  Samples will be collected with supplies provided by and analyzed by OralDNA Labs."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this research study is to determine whether and when patients with human\n      papilloma virus positive squamous cell cancer of the oropharynx treated with radiation and\n      chemotherapy clear their human papilloma virus infection."
        }, 
        "brief_title": "Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)", 
        "completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Carcinoma, Squamous Cell", 
            "Head and Neck Neoplasms", 
            "Oropharyngeal Neoplasms"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Carcinoma", 
                "Carcinoma, Squamous Cell", 
                "Head and Neck Neoplasms", 
                "Oropharyngeal Neoplasms", 
                "Papillomavirus Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. \u2265 18 years of age (no upper age limit)\n\n          2. AnyT, AnyN, M0 squamous cell carcinoma of the oropharynx\n\n          3. Biopsy proven squamous cell carcinoma that is HPV positive via standard pathological\n             assessment of tumor tissues in pathology department at the treating institution\n\n          4. Scheduled for definitive CRT as primary treatment of their oropharynx cancer\n\n        Exclusion Criteria:\n\n          1. Prior history of radiation therapy to the head and neck\n\n          2. Prior history of mucosal head and neck cancer.\n\n          3. Not willing or able to comply with study specific procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045186", 
            "org_study_id": "LCCC1338"
        }, 
        "intervention": {
            "arm_group_label": "Assessment of Oral HPV Infection", 
            "description": "Saliva and exfoliated oral epithelial cells will be collected with collection supplies provided by OralDNA Labs. Patients will swish and gargle a saline solution for 30 seconds and expectorate it into a funneled collection tube. The collected specimen will be sent to OralDNA Labs. Three diagnostic tests will be performed on each sample to assess oral HPV infection:\nPolymerase chain reaction (PCR) for HPV DNA.\nFluorescent in-situ hybridization (FISH).\nViral expression: The test is based on the measurement of the viral RNA levels by methods of detection of the fluorochrome labeled HPV probes by flow cytometry.", 
            "intervention_name": "Assessment of Oral HPV Infection", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Human Papilloma Virus", 
            "Oropharynx", 
            "Oropharyngeal Squamous Cell Carcinoma", 
            "Squamous Cell Carcinoma", 
            "Radiation Therapy", 
            "Chemotherapy"
        ], 
        "lastchanged_date": "January 24, 2014", 
        "location": {
            "contact": {
                "email": "bchera@med.unc.edu", 
                "last_name": "Bhishamjit Chera, MD", 
                "phone": "919-966-7700"
            }, 
            "contact_backup": {
                "email": "rlgreen@med.unc.edu", 
                "last_name": "Rebecca Green, MSW", 
                "phone": "(919) 445-5241"
            }, 
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599"
                }, 
                "name": "University of North Carolina at Chapel Hill, Department of Radiation Oncology"
            }, 
            "investigator": {
                "last_name": "Bhishamjit Chera, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Monitoring of Oral HPV Infection in HPV-positive Oropharyngeal Squamous Cell Carcinoma During and After Chemoradiotherapy (CRT)", 
        "overall_contact": {
            "email": "bchera@med.unc.edu", 
            "last_name": "Bhishamjit Chera, MD", 
            "phone": "(919) 966-7700"
        }, 
        "overall_contact_backup": {
            "email": "rlgreen@med.unc.edu", 
            "last_name": "Rebecca Green, MSW", 
            "phone": "(919) 445-5241"
        }, 
        "overall_official": {
            "affiliation": "University of North Carolina, Chapel Hill", 
            "last_name": "Bhishamjit Chera, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of patients with HPV-positive OPSCC undergoing CRT who are clear of their oral HPV infection at each time-point", 
            "safety_issue": "No", 
            "time_frame": "2 years post-CRT of last enrolled patient"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045186"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Time to HPV clearance for patients with HPV-positive OPSCC undergoing CRT", 
                "safety_issue": "No", 
                "time_frame": "2 years post-CRT of last enrolled patient"
            }, 
            {
                "measure": "Number of aneuploidy cells as measured by FISH (Florescent in-situ hybridization) and the mRNA copy number for HPV E6 and HPV E7 at each time-point", 
                "safety_issue": "No", 
                "time_frame": "2 years post-CRT of last enrolled patient"
            }, 
            {
                "measure": "Clinical outcomes of interest (local control, loco-regional control, distant metastasis-free survival, and overall survival (OS)) in patients with HPV-positive OPSCC undergoing CRT", 
                "safety_issue": "No", 
                "time_frame": "2 years post-CRT of last enrolled patient"
            }
        ], 
        "source": "UNC Lineberger Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNC Lineberger Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}